China Crackdown On Drug IP Infringement, Counterfeits Shifts Focus
This article was originally published in PharmAsia News
Executive Summary
China drug-enforcement authorities said they are shifting their strategy slightly to focus on regions where most of the intellectual property infringement and counterfeiting of drugs and other products are occurring.